SCHEMBL25228466

SCHEMBL25228466

CC(C)(C)OC(=O)NC1CC(O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)CC(C(=O)O)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 5/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KDM1A O60341 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ EPHX2 P34913 1/20 0.41
▸ CKS1B P61024 1/20 0.39
▸ SKP1 P63208 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ KCNA3 P22001 1/20 0.37
▸ DRD2 P14416 2/20 0.36
▸ NFKB1 P19838 2/20 0.35
▸ NFKB2 Q00653 2/20 0.35
▸ RELA Q04206 2/20 0.35
▸ BUB1 O43683 1/20 0.35
▸ HSD11B1 P28845 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30398140 0.91 KMT2A (0.43) BTKKMT2AL3MBTL1KDM1AMAOB
SCHEMBL21222073 0.86 BACE1 (0.36) HSD11B1
SCHEMBL21222072 0.86 BACE1 (0.36) HSD11B1
SCHEMBL22614223 0.86 BACE1 (0.36) HSD11B1
SCHEMBL5831941 0.84 BACE1 (0.36) L3MBTL1HSD11B1
SCHEMBL5831935 0.84 BACE1 (0.36) L3MBTL1HSD11B1
SCHEMBL14646990 0.84 KDM1A (0.53) BTKKMT2AL3MBTL1KDM1AMAOB
SCHEMBL18581937 0.83 KDM1A (0.42) BTKKMT2AL3MBTL1KDM1AMAOB
SCHEMBL2940110 0.80 BTK (0.46) BTKKMT2AL3MBTL1KDM1AMAOB
SCHEMBL2940111 0.80 BTK (0.46) BTKKMT2AL3MBTL1KDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback